Enlivex Ltd. Ordinary Shares (ENLV) is a publicly traded Healthcare sector company. As of May 21, 2026, ENLV trades at $0.71 with a market cap of $168.08M and a P/E ratio of 0.00. ENLV moved +0.54% today. Year to date, ENLV is -9.97%; over the trailing twelve months it is -28.94%. Its 52-week range spans $0.66 to $2.10. Analyst consensus is buy with an average price target of $20.00. Rallies surfaces ENLV's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Enlivex Gets 180-Day Window to Restore $1 Minimum Bid Price: Enlivex received a Nasdaq notice after its shares closed below the $1.00 minimum bid price for 30 consecutive business days. The company has 180 days until November 9, 2026 to restore a $1.00 closing bid for at least 10 consecutive days or face delisting or a reverse stock split.
| Metric | Value |
|---|---|
| Price | $0.71 |
| Market Cap | $168.08M |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $2.10 |
| 52-Week Low | $0.66 |
| Volume | 507 |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
1 analysts cover ENLV: 0 strong buy, 1 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $20.00.